Green Goo's Million Jars Have a Retail Backbone

Quick answer: the available record does not show that Green Goo reached its million-jar milestone through direct-to-consumer selling alone. Its scale had a substantial retail backbone before the brand made a sharp online pivot, and the public figures do not separate website orders from wholesale, marketplace, or later sales.

The count also needs a boundary. Green Goo's current site says "1 Million Jars Later" in one place and "1 million+ bottles sold" in another. It gives no audited period, channel split, return adjustment, or definition of a unit. The claim can describe reach. By itself, it cannot identify the machine that produced it.

The shelves came first

Green Goo began in 2008 with salves made by sisters Jodi and Jen Scott and their mother, Kathy Scott, then sold at farmers' markets. The GREEN GOO word mark was filed with the United States Patent and Trademark Office in December 2010 and registered in July 2011 for non-medicated herbal body-care salves. That chronology predates the current shorthand of an indie brand beginning with a polished online shop.

When Australia's Creso Pharma announced an agreement to acquire parent company Sierra Sage Herbs in February 2022, the seller's release described more than 90,000 US points of distribution. Its list mixed physical chains, retail websites, and Amazon. A point of distribution is not necessarily a distinct store, much less a distinct buyer, but it makes the channel architecture visible.

Creso's annual report says the acquisition was completed in August 2022 and brought access to "major retailer and online distribution channels." In later interviews, Scott has said the business was 98 percent dependent on retail when the pandemic arrived and had to pivot rapidly online. That percentage remains a founder account rather than a published channel ledger. Even so, it describes an online operation built with existing recognition, manufacturing, inventory, and retail exposure, not a cold start from a Shopify homepage.

The ownership record matters, too

Creso later became Melodiol Global Health. In December 2023, the Australian Securities and Investments Commission brought civil proceedings against former Creso director Adam Blumenthal, alleging market rigging and breaches of director duties tied to Creso shares and 2021 conduct. Those allegations concerned capital markets, not Green Goo's formulas or product sales. Keeping that boundary clear matters because founder retellings sometimes compress a complicated corporate failure into a single dramatic beat.

The Australian Securities Exchange removed Melodiol from its official list in October 2024. Administrators were appointed that December, followed by liquidators in January 2025. Green Goo announced on October 27, 2025 that the Scott family had bought the brand back. The release did not disclose the purchase terms or show how much customer data, inventory, or distribution continuity moved with it.

A million jars is therefore a cumulative volume claim, not proof of one sales model. A useful DTC test would need the direct share of revenue, customer acquisition cost, repeat-purchase rate, and contribution after fulfillment and returns, all over a named period. Those figures are not public. The bounded finding is simpler: retail created much of Green Goo's reach; direct selling became a recovery and rebuilding layer, not the only engine.

Sources: Creso Pharma annual report · Australian Securities and Investments Commission · Australian Securities Exchange · ASIC insolvency notice